![Mayo Clinic home page [logo]](/images-global/mayologo.gif)
Discover how you can help support Mayo Clinic.
View syndicated health information from Mayo Clinic.
One in eight. Those are the odds that your mom, sister, wife or friend has of getting breast cancer in her lifetime. The risk goes way up if you have one of two known breast cancer genes.
Resource: Treatment of Breast Cancer
Doctors at Mayo Clinic did a study to find out if giving women information before they have a mammogram makes a difference in their experience.
Resource: Mammography Screening
It could be your mother, sister, aunt or best friend. One out of every seven women you know will be diagnosed with breast cancer. Thankfully, advances in early detection and treatment are helping many women beat breast cancer. But there's always the fear that the cancer could come back. Now for the first time, doctors at Mayo Clinic, working with doctors in Canada and in seven other countries, have proven that a new drug can cut a woman's risk of getting a recurrence of breast cancer almost in half.
In the spring of 2006 the National Cancer Institute released initial results of the STAR trial for breast cancer prevention. The study compared the drug tamoxifen to another drug called raloxifene. Both reduced the incidence of invasive breast cancer by 50 percent in high-risk postmenopausal women.
Resource: Treatment of Breast Cancer
Ten years ago, 48,000 women -- mothers, wives, sisters -- died every year from breast cancer. Today, that number has dropped to 40,000. But it's still too high. That's why many women who are at high risk of getting breast cancer choose genetic testing.
Resource: Breast Cancer Risk Assessment
.
